Increasing population ageing will increase health expenditure in an unpredictable way as new available therapeutic options and future development in cardiovascular treatment expand the health market and therefore the expectancy of life span and of symptom relief. Heart failure, the new millennium pandemic in the growing-old population, will probably be a frequent battlefield where cardiologist and general practitioner have to cope with the need and the demand of health services. Personalization of care profiles will be a key issue for patient satisfaction and optimal resource allocation. New technological advances will allow different pathways for patient follow-up both in the prevention and treatment of unpredicted events. A different philosophy will be required in adopting expensive therapeutic solutions. Quality assurance, both of consolidated treatments and of more advanced therapeutic options, will be the cornerstone to make increased health cost productive and socially acceptable. (C) 2000 The European Society of Cardiology.
|Journal||European Heart Journal, Supplement|
|Publication status||Published - 2000|
- Heart failure
- Monitoring devices
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine